Repare Therapeutics Inc. (RPTX)
$2.65+0.00%Close
BUYBULL · day 29
Key stats
- Market cap
- $114M
- Beta
- 0.96
- P/E (TTM)
- -8.43
- 1W
- +2.32%
- 1M
- +3.11%
- vs SPY 1W
- +2.46%
- vs SPY 1M
- +0.61%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 12
- GROWTH
- 16
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-7.2%
REV YoY-
ROE-12.0%
EPS YoY-
ROA-10.6%
GROSS37
OP-140
NET-114
[VALUATION]
P/E TTM-8.43
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.99
P/FCF-
EV/EBITDA-2.15
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.30
ALTMAN Z-
CURR RATIO10.71
ND/EBITDA-
BETA0.96
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on RPTX?
- LOPJLB’s latest quantitative signal on Repare Therapeutics Inc. (RPTX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is RPTX in?
- Repare Therapeutics Inc. (RPTX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Repare Therapeutics Inc. (RPTX) do?
- Repare Therapeutics Inc. is a precision oncology biopharmaceutical company in the clinical stage, focused on discovering and developing innovative therapies. Operating across Canada and the United States, the company leverages a synthetic lethality approach to identify new treatments. Central to their efforts is the proprietary, genome-wide, and CRISPR-enabled SNIPRx platform, which systematica…